Therapeutic Hypothermia With Propofol in Survival and Neurological Prognoses After Cardiac Arrest

Summary

Therapeutic hypothermia has been proven to significantly improve the survival and neurological prognoses in patients resuscitated from cardiac arrest. Propofol has been reported to exhibit potentials in mitigating ischemia-reperfusion injury via the antioxidative, anti-inflammatory and neuroprotective mechanisms. This study is to investigate the potentials of propofol in further improving the survival and neurological prognoses in this era of therapeutic hypothermia.

Timeline

Start

2013-08

Primary completion

2016-12

Completion

2016-12

Drugs

Indications